BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17722858)

  • 1. Why I raise money for kidney disease research.
    Ditschman EP
    Nephrol News Issues; 2007 Aug; 21(9):56. PubMed ID: 17722858
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomedical philanthropy: state of the donation.
    Wadman M
    Nature; 2007 May; 447(7142):248-50. PubMed ID: 17507953
    [No Abstract]   [Full Text] [Related]  

  • 3. Freedom to fund.
    Aschwanden C
    Cell; 2007 Feb; 128(3):421-3. PubMed ID: 17289559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. So why not start a foundation?
    Foote J; Ziller L
    Found News; 1984; 25(3):50-8. PubMed ID: 10267288
    [No Abstract]   [Full Text] [Related]  

  • 5. Fund-raising: how and why.
    Bowers JL
    Trustee; 1990 Dec; 43(12):10-1. PubMed ID: 10108128
    [No Abstract]   [Full Text] [Related]  

  • 6. In praise of Gates.
    Nature; 2003 Oct; 425(6957):435. PubMed ID: 14523403
    [No Abstract]   [Full Text] [Related]  

  • 7. Gates steps up war on malaria with donation of 168 million dollars.
    Butler D
    Nature; 2003 Sep; 425(6956):331. PubMed ID: 14508444
    [No Abstract]   [Full Text] [Related]  

  • 8. Why we or they? The potential for conflict between the foundation's board and the hospital's.
    Lamkins RG
    J Natl Assoc Hosp Dev; 1984; ():33, 35. PubMed ID: 10310736
    [No Abstract]   [Full Text] [Related]  

  • 9. A grant for every purpose.
    Hertz WJ; Kurzig CK
    Found News; 1983; 24(1):26-31 contd. PubMed ID: 10259986
    [No Abstract]   [Full Text] [Related]  

  • 10. The Michigan Dental Foundation: building and expanding in 2005.
    Curcuru GA
    J Mich Dent Assoc; 2005 Apr; 87(4):32, 34-44. PubMed ID: 16050559
    [No Abstract]   [Full Text] [Related]  

  • 11. Advantages and limitations of hospital foundations.
    Michaels JL
    OH; 1981 Sep; 25(8):14-7, 22. PubMed ID: 10252487
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital foundations: pros and cons should be considered.
    Bachrach B
    Fund Raising Manage; 1978; 9(3):36-9, 50-1. PubMed ID: 10308094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auxiliaries and foundations: a collaborative model.
    Shapiro C
    Volunt Leader; 1993; 34(1):6-7. PubMed ID: 10124344
    [No Abstract]   [Full Text] [Related]  

  • 14. Ohio hospital's "ESP" plan symbolizes Kellogg Foundation's health assistance.
    Rev Fed Am Hosp; 1979 Feb; 12(1):51-3. PubMed ID: 10240041
    [No Abstract]   [Full Text] [Related]  

  • 15. Funding: Donor drugs.
    Willyard C
    Nature; 2016 May; 533(7601):S43-5. PubMed ID: 27144609
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone and joint diseases around the world. USA: arthritis foundation research, collaboration, and advocacy.
    Riggin DL
    J Rheumatol Suppl; 2003 Aug; 67():32. PubMed ID: 12926649
    [No Abstract]   [Full Text] [Related]  

  • 17. Pros and cons of hospital development foundations.
    Smith SR
    Trustee; 1982 Mar; 35(3):46, 48. PubMed ID: 10254672
    [No Abstract]   [Full Text] [Related]  

  • 18. Research philanthropy. Billionaire restores funding for novel biomedical network.
    Couzin-Frankel J
    Science; 2012 Nov; 338(6109):873-4. PubMed ID: 23161965
    [No Abstract]   [Full Text] [Related]  

  • 19. Kellogg's view of volunteerism.
    Brown NA
    Volunt Leader; 1991; 32(3):6. PubMed ID: 10112818
    [No Abstract]   [Full Text] [Related]  

  • 20. A unique fellows program for up-and-coming fund raisers.
    Rosser DJ; Murphy JP
    J Assoc Healthc Philanthr; 1993; ():25-8. PubMed ID: 10125182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.